Wei, Z., Chen, H., Chen, F., Liu, J., Peng, X. (2025). Neoadjuvant chemoimmunotherapy with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-2): An open-label, single-arm, phase 2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6069